Utama › Kanser Kolorektal › Ohio › Cincinnati
Kajian klinikal Kanser Kolorektal di Cincinnati, OH
21 kajian untuk Kanser Kolorektal sedang mencari peserta di lokasi dalam dan sekitar Cincinnati (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
- Oncology Hematology Care - Blue Ash /ID# 280143, Cincinnati
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- Bethesda North Hospital, Cincinnati
- dan 3 lagi
Family Communications After Genetic Testing
Mengambil pesertaSukarelawan sihat dialu-alukan
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Oncology Hematology Care Inc-Kenwood, Cincinnati
- dan 4 lagi
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Mengambil pesertaFasa 1
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi jauh
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Mengambil pesertaFasa 2
- Oncology Hematology Care - Eastgate /ID# 271493, Cincinnati
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
- Oncology Hematology Care - Eastgate, Cincinnati
- Oncology Hematology Care Clinical Trials, LLC, Fairfield · 15 mi jauh
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Mengambil pesertaFasa 2
- Research Site, Cincinnati
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Mengambil pesertaFasa 1/2
- University of Cincinnati Medical Center, Cincinnati
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Mengambil pesertaFasa 3
- University of Cincinnati Cancer Institute, Cincinnati
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
Mengambil pesertaFasa 3
- Clinical Study Site, Cincinnati
- Clinical Study Site, Cincinnati
- Clinical Study Site, Edgewood · 8 mi jauh
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
Mengambil pesertaFasa 1
- University of Cincinnati Cancer Center, Cincinnati
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Mengambil pesertaFasa 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
Mengambil pesertaFasa 1
- University of Cincinnati (UC) - Cancer Institute, Cincinnati
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
Mengambil pesertaFasa 1
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- University of Cincinnati Cancer Center-West Chester, West Chester · 15 mi jauh
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Oncology Hematology Care Primary, Cincinnati
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Mengambil pesertaFasa 1/2
- University of Cincinnati Cancer Center, Cincinnati
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Mengambil pesertaFasa 1
- The Christ Hospital, Cincinnati
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
Mengambil pesertaFasa 1/2
- Christ Hospital Cancer Center, Cincinnati
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
Mengambil pesertaFasa 3Sukarelawan sihat dialu-alukan
- Good Samaritan Hospital - Cincinnati, Cincinnati
- Bethesda North Hospital, Cincinnati
- TriHealth Cancer Institute-Westside, Cincinnati
- dan 1 lagi
64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer
Mengambil pesertaFasa 1/2
- Cincinnati Children's Hospital Medical Center, Cincinnati
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Mengambil pesertaKajian pemerhatian
- TriHealth Cancer Institute, Cincinnati
Kajian Kanser Kolorektal di bandar lain
- Houston, TX102 kajian
- New York City, NY77 kajian
- Nashville, TN69 kajian
- Boston, MA63 kajian
- Los Angeles, CA59 kajian
- Arlington, VA52 kajian
- St. Louis, MO50 kajian
- San Antonio, TX46 kajian
- Philadelphia, PA44 kajian
- Grand Rapids, MI40 kajian
- Baldwin Park, CA38 kajian
- Seattle, WA34 kajian
Kajian lain di Cincinnati
- Kanser Paru-paru Bukan Sel Kecil35 kajian
- Kanser (semua jenis)27 kajian
- Kanser Payudara25 kajian
- Kegagalan Jantung24 kajian
- Leukemia Mieloid Akut20 kajian
- Kanser Metastatik20 kajian
- Kanser Ovari19 kajian
- Kanser Paru-paru19 kajian
- Obesiti19 kajian
- Kanser Prostat18 kajian
- Mieloma Pelbagai17 kajian
- Melanoma17 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.